Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07203755) titled 'Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine' on Sept. 25.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: CanSino Biologics Inc.
Condition:
Diphtheria, Tetanus and Acellular Pertussis
Epidemic Meningitis
Haemophilus Influenzae Type B Infection
Intervention:
Biological: Adsorbed Acellular Pertussis (3-Comp...